Many Don’t Get Preferred Heart Failure Drug

Most people in the hospital for heart failure don’t get sent home with a drug that could prevent a return visit, a study finds. The drug is spironolactone, a water pill. This drug helps to prevent fluid buildup in the lungs, blood and elsewhere in people with heart failure. It has been shown to reduce hospital stays and deaths. But it also can be dangerous in some people, such as those with kidney problems. The study included 201 hospitals. More than 12,500 patients were eligible to receive spironolactone. But only about one-third received the pills. Guidelines for doctors have recommended this drug for heart failure since 2005. The study appeared in the Journal of the American Medical Association. The Associated Press wrote about it October 21.